Stay updated on LN-145 + Pembrolizumab in Transitional Cell Cancer Clinical Trial

Sign up to get notified when there's something new on the LN-145 + Pembrolizumab in Transitional Cell Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LN-145 + Pembrolizumab in Transitional Cell Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.5 to v3.6.6. This reflects a deployment of updates to the page template or metadata without changes to the study data.
    Difference
    0.1%
    Check dated 2026-08-29T21:43:09.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.4 to v3.6.5, indicating a minor update to the page template. This does not appear to modify any study details or eligibility information.
    Difference
    0.1%
    Check dated 2026-08-08T20:34:24.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Revision: v3.6.4 is now displayed on the page, replacing v3.6.3. This indicates a minor update to the page template or underlying content management system.
    Difference
    0.1%
    Check dated 2026-07-25T12:57:31.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Revision: v3.6.3 is now displayed on the page, replacing the previous v3.6.2. This reflects a minor update to the page’s revision tag without changes to the study content.
    Difference
    0.1%
    Check dated 2026-07-04T03:47:57.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.0 to v3.6.2, indicating a newer version of the page used for maintenance. This update does not modify visible content.
    Difference
    0.1%
    Check dated 2026-06-27T01:25:32.000Z thumbnail image
  9. Check
    81 days ago
    Change Detected
    Summary
    The page loses several regulatory and documentation labels, including FDA-regulated status and IPD-related terms, along with associated descriptors, which changes how regulatory context and study documents are surfaced.
    Difference
    19%
    Check dated 2026-06-19T22:42:06.000Z thumbnail image

Stay in the know with updates to LN-145 + Pembrolizumab in Transitional Cell Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LN-145 + Pembrolizumab in Transitional Cell Cancer Clinical Trial page.